Invesco Ltd. Castle Biosciences Inc Transaction History

Invesco Ltd.

$453 Billion
Q1 2024

A detailed history of Invesco Ltd. transactions in Castle Biosciences Inc stock. As of the latest transaction made, Invesco Ltd. holds 27,396 shares of CSTL stock, worth $596,410. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,396

Previous 32,156 14.8%

Holding current value

$596,410

Previous $693,000 12.55%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$18.06 - $25.3 $85,965 - $120,428	-4,760 Reduced 14.8%	27,396 $606,000
Q4 2023 Feb 12, 2024	SELL	$12.19 - $22.43 $46,334 - $85,256	-3,801 Reduced 10.57%	32,156 $693,000
Q3 2023 Nov 13, 2023	BUY	$13.28 - $20.3 $162,520 - $248,431	12,238 Added 51.6%	35,957 $607,000
Q2 2023 Aug 11, 2023	BUY	$11.66 - $26.0 $9,491 - $21,164	814 Added 3.55%	23,719 $325,000
Q1 2023 May 12, 2023	BUY	$19.47 - $28.49 $73,635 - $107,749	3,782 Added 19.78%	22,905 $520,000

Q4 2022 Feb 13, 2023	SELL	$18.08 - $30.0 $5.91 Million - $9.81 Million	-326,856 Reduced 94.47%	19,123 $450,000
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $64,896 - $98,944	-2,883 Reduced 0.83%	345,979 $9.02 Million
Q2 2022 Aug 15, 2022	SELL	$16.0 - $45.99 $11.7 Million - $33.6 Million	-730,170 Reduced 67.67%	348,862 $7.66 Million
Q1 2022 May 16, 2022	BUY	$33.17 - $46.98 $974,269 - $1.38 Million	29,372 Added 2.8%	1,079,032 $48.4 Million
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $703,158 - $1.22 Million	18,002 Added 1.74%	1,049,660 $45 Million
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $6.41 Million - $8.27 Million	-106,594 Reduced 9.36%	1,031,658 $68.6 Million
Q2 2021 Aug 17, 2021	BUY	$50.07 - $76.78 $5.59 Million - $8.56 Million	111,547 Added 10.86%	1,138,252 $83.5 Million
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $5.45 Million - $9 Million	-92,418 Reduced 8.26%	1,026,705 $70.3 Million
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $45.2 Million - $75.7 Million	1,035,819 Added 1243.42%	1,119,123 $75.1 Million
Q3 2020 Nov 16, 2020	BUY	$38.47 - $52.03 $2.55 Million - $3.45 Million	66,367 Added 391.85%	83,304 $4.29 Million
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $462,041 - $728,460	16,937 New	16,937 $638,000

Others Institutions Holding CSTL

# of Institutions

162

Shares Held

25.3M

Call Options Held

82.2K

Put Options Held

150K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $572M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account